Live Quote · NASDAQRNTXHealthcare· Biotechnology

Rein Therapeutics Inc.

$0.34▼ 8.38%($-0.03)
MKT CAP $29.06MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
80
Valuation
20
Profitability
60
Growth
72
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RNTX research report →

Analyst Price Target
$6.00+1680.9% vs. today

Range $6 – $6

Analyst RatingBuy
1 Buy1 Hold0 Sell

Price Chart

-75.59% · this period
$1.88$1.11$0.34Nov 20May 26Nov 20
52-Week Range3% of range
Low
$0.28
Current
$0.34
High
$2.10